Skyepharma Productions SAS
Is this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Chemistry, Manufacturing and Controls
Regulatory, Tech Transfer & Support Services
Contract Research Organization
Company Overview
About
No description available
Key Expertise
complex oral solid dose formulation, modified release technologies, HPAPI handling (OEB 4/5), orphan drugs, press-coated tablets, multi-layer tablets
Therapeutic Areas
Oncology
Orphan Drugs
Rare Diseases
Quick Facts
HQ:France
Capabilities & Services
Core Capabilities
- Small Molecule Drug Product
- Oral Solid Dose
- Formulation Development
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
DEA Schedule II-V
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Phase I Clinical Trials
Phase II
Clinical
Phase III Clinical Trials
Commercial Scale
Markets Served
Europe
Manufacturing Facilities
3 sites worldwide
Skyepharma Productions SAS - France Facility
France
Skyepharma Productions SAS - France Facility
France
Site Capabilities
3 capabilitiesQuality Control
Stability Testing
Method Development
SKYEPHARMA (Skyepharma Productions SAS) - France Facility
France
Site Capabilities
3 capabilitiesGene Therapy
Cell Therapy
mRNA
Certifications
FDA Registration
U.S. Food and Drug Administration
EMA GMP Certificate
European Medicines Agency